Investor Presentaiton
BY 2030, INDIA CAN BECOME 5TH LARGETS MARKET GLOBALLY
India is among the top 20 pharmaceutical
exporters.
Indian drugs are exported to more than 200
countries globally with US and Europe as
major export destinations.
Pharmaceutical exports are expected to
reach US$ 20 billion by 2020.
are
The major therapeutic categories of export
anti-infective, anti-asthmatic and
anti-hypertensive.
India is the global leader in production of
generic medicines, country's generic drugs
account for almost 20% of global generic
medicine exports (by volume).
The Indian medical device market reached
US$ 4.9 billion in 2019 and is expected to
exceed US $7 billion by 2020.
UN supported Medicines Patent Pool (MPP)
has signed six sub-licences with Indian
firms. This licence allows them to produce
generic anti-AIDS medicine for sale in 112
developing countries.
EXPORT DATA OF INDIAN
PHARMACEUTICALS
(US$ BILLION)
12.6
10.1
CAGR: 9.53%
14.5 14.9
16.9 168 17.3
19.1
Sources: http://planningcommission.gov.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf
https://www.ibef.org/industry/pharmaceutical-india.aspx
The Indian Pharmaceutical industry - the way forward, report by Indian Pharmaceutical Alliance
https://www.export.gov/article?id=India-Healthcare-and-Medical-Equipment
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
Source: IBEF Research, Department of Commerce,
Department of Pharmaceuticals, India Business News, BMIView entire presentation